CURE vs SCHD
Direxion Daily Healthcare Bull 3X ETF vs Schwab US Dividend Equity ETF
Quick Verdict
SCHD has a lower expense ratio. CURE delivered stronger 1-year returns. SCHD offers more diversification with 100 holdings.
Side-by-Side Comparison
| Metric | CURE | SCHD | Winner |
|---|---|---|---|
| Expense Ratio | 0.94% | 0.06% | |
| AUM | $181M | $103.7B | |
| Dividend Yield | 1.12% | 3.31% | |
| Holdings | 67 | 104 | |
| YTD Return | +11.58% | +24.26% | |
| 1Y Return | +87.78% | +31.38% | |
| 3Y Return (annualized) | +7.97% | +15.08% | |
| 5Y Return (annualized) | +1.36% | +9.72% | |
| Volatility (annualized) | 41.9% | 13.6% | |
| Max Drawdown | -69.2% | -33.4% | |
| Fund Family | Direxion Shares ETF Trust | Charles Schwab Asset Management | |
| Category | Alternative | Equity | |
| Inception | Jun 15, 2011 | Oct 20, 2011 |
CURE vs SCHD Performance
Direxion Daily Healthcare Bull 3X ETF (CURE) is a ETF from Direxion Shares ETF Trust and Schwab US Dividend Equity ETF (SCHD) is a ETF from Charles Schwab Asset Management. Over the past year CURE returned +87.78% while SCHD returned +31.38%. Year to date, CURE is up 11.58% versus a gain of 24.26% for SCHD.
Over three years, CURE compounded at +7.97% per year against +15.08% for SCHD; over five years the annualized figures are +1.36% and +9.72% respectively. Across the full 15-year window we track, CURE has the edge at +24.18% annualized vs +11.39%. Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
CURE has been the more volatile fund, with annualized monthly volatility of 41.9% compared with 13.6% for SCHD. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -69.2% for CURE and -33.4% for SCHD. Drawdown depth is worth weighing if you expect to sell during market stress rather than ride it out.
The two funds' monthly returns correlate at 0.74. They usually move together, but the gap leaves some room for diversification.
Fees and Cost Over Time
CURE charges 0.94% per year while SCHD charges 0.06%. On a $10,000 position that is $94 vs $6 annually, a gap of $88 per year that compounds over a long holding period. On income, CURE currently yields 1.12% against 3.31% for SCHD.
Holdings Overlap
CURE and SCHD share 5 holdings out of 157 unique holdings combined, representing a 13.9% weight overlap.
Moderate overlap means holding both could provide meaningful diversification benefits.
Frequently Asked Questions
Which is cheaper, CURE or SCHD?
CURE has an expense ratio of 0.94% while SCHD charges 0.06%. SCHD is the cheaper option. On a $10,000 investment, that is $88 per year of difference.
Which performed better, CURE or SCHD?
Over the past year CURE returned +87.78% vs +31.38% for SCHD, so CURE leads on 1-year performance. Over the longest common window we track (15 years), CURE annualized +24.18% vs +11.39% for SCHD. Past performance does not guarantee future results.
Which is riskier, CURE or SCHD?
CURE has been the more volatile fund at 41.9% annualized versus 13.6% for SCHD. Worst drawdown: CURE -69.2% vs SCHD -33.4%.
Should I hold both CURE and SCHD?
CURE and SCHD have a monthly-return correlation of 0.74, so combining them can provide real diversification depending on your allocation goals.
What is the holdings overlap between CURE and SCHD?
CURE and SCHD share 5 common holdings with a 13.9% weight overlap. Combined, they hold 157 unique securities.
Which pays a higher dividend, CURE or SCHD?
CURE yields 1.12% while SCHD yields 3.31%, so SCHD currently pays the higher dividend yield.
Popular ETF Comparisons
Get Full ETF Analytics
Access complete holdings data, overlap analysis, screener tools, and more with FundXLS.